Business Standard

Indivior says U.S. court rules against generic rival's appeal


(Reuters) - Indivior Plc said on Tuesday a U.S. court ruled against Dr. Reddy's Laboratories appeal for lifting the preliminary injunction on the rival's copycat opioid addiction treatment in the United States.
The British drugmaker was granted a preliminary injunction earlier this month that prevented Dr. Reddy's from selling its copycat version.
(Reporting by Sangameswaran S in Bengaluru; Editing by Amrutha Gayathri)

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jul 31 2018 | 12:19 PM IST

Explore News